George Adi Mor insider trades: Chemomab Therapeutics (CMMB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | CMMB | ↑ Buy | 9,804 | $2.07 | $20K | Direct | Jun 1, 2026 (3d) |
| Jan 3, 2023 | CMMB | ↓ Sell | 7,700 | $5.03 | $39K | Direct | Jan 5, 2023 (2d) |
| Jan 3, 2023 | CMMB | ↓ Sell | 6,100 | $5.03 | $31K | By Kobi George, the Reporting Person's s | Jan 5, 2023 (2d) |
| Nov 16, 2022 | CMMB | ↓ Sell | 324,775 | $2.08 | $677K | Direct | Nov 17, 2022 (1d) |
| Nov 16, 2022 | CMMB | ↓ Sell | 257,248 | $2.08 | $536K | By Spouse | Nov 17, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CMMB insiders
Open-market trades in the last 12 months
About George Adi Mor's insider trades
George Adi Mor is Chief Executive Officer at Chemomab Therapeutics (CMMB). Since Nov 16, 2022, George has reported 1 open-market purchase worth $20K and 4 sales worth $1.3M on SEC Form 4. In the last 12 months: 1 buy ($20K).
Their filings also include grants and awards (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMMB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.